Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. Khanna et al therefore investigated the effectiveness of angiotensin II for the treatment of patients with this condition.
They found that angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors.
Read the full Concise Critical Appraisal by logging into the SCCM eCommunity. Concise Critical Appraisal is a regular feature aimed at highlighting the best and most relevant literature from a variety of academic journals and encouraging discussion around recent studies and research.